Ann Menefee

Title: Ann Menefee: Innovator in Neuropilin-2 Research

Introduction

Ann Menefee is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biomedical research, particularly in the development of therapeutic compositions targeting neuropilin-2 (NRP2). With a total of two patents to her name, her work is paving the way for advancements in treating NRP2-associated diseases.

Latest Patents

Ann Menefee's latest patents focus on compositions and methods comprising anti-NRP2 antibodies. These patents provide antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 polypeptides. The innovations include methods that modulate binding interactions between human NRP2 and at least one NRP2 ligand, such as human histidyl-tRNA synthetase (HRS). This modulation can influence downstream signaling events related to NRP2, offering potential therapeutic applications for treating various diseases associated with NRP2.

Career Highlights

Ann Menefee is currently associated with Atyr Pharma, Inc., where she continues her research and development efforts. Her work is instrumental in advancing the understanding of NRP2 and its implications in disease treatment.

Collaborations

Some of her notable coworkers include Luke Burman and Yee Ting (Esther) Chong, who contribute to her research endeavors.

Conclusion

Ann Menefee's innovative work in the field of neuropilin-2 research exemplifies the impact of dedicated inventors in advancing medical science. Her contributions are vital for the development of new therapeutic strategies.